Study of Anlotinib in Patients With Advanced Medullary Thyroid Carcinoma
Clinical trial NCT05830500 · RECRUITING
Trial details
- NCT number
- NCT05830500
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-19
- Primary completion
- 2027-06-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.